Gwenn Hansen

Company: Nurix Therapeutics

Job title: Chief Scientific Officer


Panel Discussion: KOL Future Advisory Panel 9:30 am

At a time when the TPD community is poised for more clinical success yet continues to battle for available funding to progress this pioneering drug modality, its crucial we heed the knowhow and experience of the field’s thought leaders. Here we have our TPD Future Advisory Panel Where should the field’s focus be on tackling…Read more

day: Day 2 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.